Products

Products

Nexavar® companion diagnostic test for HCC

  • Nexavar® is a first line molecular-targeted agent in advanced hepatocellular carcinoma (HCC) treatment.
  • A clinically validated Nexavar® companion diagnostic test for HCC is able to improve the treatment outcome via patients stratification.
    • Drug : NEXAVAR® (Sorafenib)
    • Manufacturer : Bayer AG
    • Indication : HCC, RCC (advanced)
    • Patent expiration : 2020(US), 2021(EU)